Autoimmune Diseases  >>  Nulojix (belatacept)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nulojix (belatacept) / BMS
NCT01033500: Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

Withdrawn
N/A
0
US
Belatacept
University of Wisconsin, Madison, Bristol-Myers Squibb
Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney Transplantation
12/12
12/12
NCT02500498: Safety Profile of Nulojix in Home Infusion Settings

Completed
N/A
37
RoW
Nulojix
Bristol-Myers Squibb, BiologicTx, LLC
Rheumatoid Arthritis
06/15
06/15

Download Options